Patients with severe COVID-19 are 90% more likely to see better outcomes when taking hydrocortisone, finds research

Patients with severe COVID-19 who are treated intravenously with the steroid hydrocortisone are up to 93% more likely to have a better outcome compared with patients who are not given the drug, findings from a major COVID-19 trial published in JAMA have suggested.…